These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3521850)

  • 1. Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial.
    DeSimone PA; Gams R; Bartolucci A
    Cancer Treat Rep; 1986 Jul; 70(7):929-30. PubMed ID: 3521850
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
    DeSimone PA; Gams R; Birch R
    Cancer Treat Rep; 1986 Aug; 70(8):1043-4. PubMed ID: 3524836
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
    Gams RA; Nelson O; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
    Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
    Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
    Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
    Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
    Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
    Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
    Williams SD; Birch R; Gams R; Irwin L
    Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
    Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trial of mitoxantrone.
    Anderson KC; Cohen GI; Garnick MB
    Cancer Treat Rep; 1982 Nov; 66(11):1929-31. PubMed ID: 7139638
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
    Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract]   [Full Text] [Related]  

  • 12. Weekly mitoxantrone therapy for refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
    Esseesse I; Bartolucci AA; Gams RA; Silberman H; Velez-Garcia E; Cohen HJ; Omura GA
    Cancer Treat Rep; 1986 May; 70(5):669-70. PubMed ID: 3708615
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of metastatic sarcomas with mitoxantrone.
    Presant CA; Gams R; Bartolucci AA
    Cancer Treat Rep; 1984 May; 68(5):813-4. PubMed ID: 6722837
    [No Abstract]   [Full Text] [Related]  

  • 14. First-line mitoxantrone chemotherapy for advanced breast cancer.
    Wilson KS; Paterson AH
    Cancer Treat Rep; 1986 Aug; 70(8):1021-2. PubMed ID: 3731148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone in malignant melanoma.
    Presant CA; Gams R; Bartolucci A
    Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of esorubicin in advanced pancreatic adenocarcinoma.
    Blayney DW; Goldberg DA; Leong LA; Carr BI; Doroshow JH
    Cancer Treat Rep; 1986 May; 70(5):683-4. PubMed ID: 3708621
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase II study of mitoxantrone in advanced breast cancer].
    Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
    Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of mitoxantrone in patients with primary liver cancer.
    Falkson G; Coetzer BJ; Terblanche AP
    Cancer Treat Rep; 1984 Oct; 68(10):1311-2. PubMed ID: 6525607
    [No Abstract]   [Full Text] [Related]  

  • 19. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
    Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1538-9. PubMed ID: 6347083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.